Evidence by drug
Metronomic temozolomide
97 studies and 25 trials indexed. 10 trials are recruiting or about to start.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
Trials recruiting or starting soon
- RecruitingEarly phase 1CanadaNCT06942039Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationC17 Council
- RecruitingPhase 1United StatesNCT05106296Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerTheodore S. Johnson
- RecruitingPhase 2Austria, Czechia, Denmark, and 5 moreNCT01356290Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS TumorsMedical University of Vienna
- RecruitingPhase 1, Phase 2FranceNCT07243470Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System TumorsCentre Leon Berard
- RecruitingPhase 1United StatesNCT05698524A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent GliomaUniversity of Nebraska
- RecruitingEarly phase 1United StatesNCT03122197Study of Letrozole in Recurrent GliomasUniversity of Cincinnati
- RecruitingPhase 1, Phase 2Denmark, France, Italy, and 3 moreNCT02813135European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsGustave Roussy, Cancer Campus, Grand Paris
- RecruitingPhase 1, Phase 2FranceNCT05384821Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)Centre Oscar Lambret
- RecruitingPhase 2ItalyNCT05554003Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe StudyEuropean Institute of Oncology
- Not yet recruitingPhase 1, Phase 2United StatesNCT07859059Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/GlioblastomaUniversity of Nebraska
Newest studies
- StudyTransl Cancer Res2026 Aug 31A single-center retrospective study evaluating the efficacy of anlotinib plus temozolomide for recurrent glioma based on real-world data.Huang Y, et al.
- Case reportFront Oncol2026Low-dose temozolomide combined with valproic acid in the treatment of an elderly patient with MGMT-methylated glioblastoma and multiple comorbidities: a case report.Gan L and Ma Y
- StudyTissue Eng Part C Methods2026 MayThe Size of Glioblastoma Spheroids Influences Patterns of Invasion and Temozolomide Efficacy.Fok S, et al.
- Clinical trialNat Commun2026 Apr 10Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study.Cives M, et al.
- StudyAdv Nanobiomed Res2026 Feb 24Heterogenous Model of Temozolomide Resistance in Glioblastoma Reveals Phenotypic Shifts in Drug Response and Migratory Potential.Kriuchkovskaia VA, et al.
- StudyJ Biomed Mater Res A2026 FebHydrogel Microdroplet Based Glioblastoma Drug Screening Platform.Payan BA, et al.
- Clinical trialNeuro Oncol2026 Feb 1Phase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas.Schiff D, et al.
- StudybioRxiv2025 Aug 6Size-dependent invasion and therapeutic phenotype of 42MGBA glioblastoma spheroids.Fok S, et al.
- StudybioRxiv2025 Jul 12Hydrogel microdroplet based glioblastoma drug screening platform.Payan BA, et al.
- StudybioRxiv2025 Jul 11Multicellular Model of Temozolomide Resistance in Glioblastoma Reveals Phenotypic Shifts in Drug Response and Migratory Potential.Kriuchkovskaia VA, et al.
- StudyBiomedicines2024 Dec 6Mutations in the PIK3C2B, ERBB3, KIT, and MLH1 Genes and Their Relationship with Resistance to Temozolomide in Patients with High-Grade Gliomas.Ortiz Gómez LD, et al.
- ReviewChilds Nerv Syst2024 OctChemotherapy in pediatric low-grade gliomas (PLGG).Lassaletta A, et al.
- Randomized trialLancet Oncol2024 JulIrinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.Corbacioglu S, et al.
- Clinical trialESMO Open2024 MayA new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial.von Arx C, et al.
- StudyBr J Cancer2024 MayTumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.Cao Q, et al.
- StudyClin Oncol (R Coll Radiol)2023 MayMetronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study.Bosio A, et al.
- Case reportFront Oncol2023(125)I Radiotherapy combined with metronomic chemotherapy may boost the abscopal effect, leading to complete regression of liver metastasis in an SCLC patient with a 58.5-month OS: a case report.Lu L, et al.
- Clinical trialClin Cancer Res2023 Apr 14Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases.Jenkins S, et al.
- StudyJ Neuroendocrinol2022 OctMetronomic chemotherapy in patients with advanced neuroendocrine tumors: A single-center retrospective analysis.Arrivi G, et al.
- StudyCancer Chemother Pharmacol2022 MayPharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors.Büsker S, et al.
- StudyCancers (Basel)2021 Dec 14Accumulation of Temozolomide-Induced Apoptosis, Senescence and DNA Damage by Metronomic Dose Schedule: A Proof-of-Principle Study with Glioblastoma Cells.Beltzig L, et al.
- StudyNeuro Endocrinol Lett2021 Nov 30A retrospective observational study on cases of anaplastic brain tumors treated with the Di Bella Method: A rationale and effectiveness.Di Bella G, et al.
- StudyPharmaceuticals (Basel)2021 Nov 29In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma.Halatsch ME, et al.
- StudyNeurooncol Adv2021 Jan-DecA phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3.Halatsch ME, et al.
- Clinical trialClin Cancer Res2021 Jun 15Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas.Wu J, et al.
- Clinical trialAm J Clin Oncol2021 Feb 1Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group Trial.Elinzano H, et al.
- StudyInt J Med Sci2021Comparing mTOR inhibitor Rapamycin with Torin-2 within the RIST molecular-targeted regimen in neuroblastoma cells.Waetzig R, et al.
- ReviewCurr Opin Oncol2021 JanAdrenocortical carcinoma: current treatment options.De Filpo G, et al.
- ReviewJ Neurooncol2021 JanTemozolomide treatment outcomes and immunotherapy efficacy in brain tumor.Hotchkiss KM and Sampson JH
- StudyClinics (Sao Paulo)2020Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide.Faustino AC, et al.
- StudyCancer Chemother Pharmacol2020 SepTemozolomide desensitization followed by metronomic dosing in patients with hypersensitivity.Neth BJ, et al.
- Clinical trialFuture Oncol2020 MayTemozolomide in secondary prevention of HER2-positive breast cancer brain metastases.Zimmer AS, et al.
- StudyNMR Biomed2020 AprAnti-tumour immune response in GL261 glioblastoma generated by Temozolomide Immune-Enhancing Metronomic Schedule monitored with MRSI-based nosological images.Wu S, et al.
- StudyMelanoma Res2019 DecExceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma.Swami U, et al.
- StudyJ Clin Med2019 Aug 15Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.Tafuto S, et al.
- StudyNeuro Oncol2019 Jun 10Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition.Karachi A, et al.
- ReviewExp Clin Endocrinol Diabetes2019 FebMetastatic Phaeochromocytoma: Spinning Towards More Promising Treatment Options.Nölting S, et al.
- Case reportKlin Onkol2019 WinterEffective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome.Pavelka Z, et al.
- StudyJ Theor Biol2018 Jun 7Administration of temozolomide: Comparison of conventional and metronomic chemotherapy regimens.Houy N and Le Grand F
- Case reportClin Med Insights Oncol2018Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature.Tena I, et al.
